Geneva, Switzerland, April 23, 2026-Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric ...
Addex Therapeutics Ltd (ADXN), a clinical-stage biopharmaceutical company specializing in innovative treatments for neurological disorders, is set to release its official Q3 2024 financial results on ...
Participants are required to register in advance of the conference using the link provided below. Upon registering, each participant will be provided with Participant Dial-in numbers, and a unique ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results